Affiliation:
1. Interdisciplinary Graduate Program in Genetics and Genomics, Texas A&M University, College Station, TX 77845, USA
2. Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Bryan, TX 77807, USA
Abstract
Numerous potential drug targets, including G-protein-coupled receptors and ion channel proteins, reside on the cell surface as multi-pass membrane proteins. Unfortunately, despite advances in engineering technologies, engineering biologics against multi-pass membrane proteins remains a formidable task. In this review, we focus on the different methods used to prepare/present multi-pass transmembrane proteins for engineering target-specific biologics such as antibodies, nanobodies and synthetic scaffold proteins. The engineered biologics exhibit high specificity and affinity, and have broad applications as therapeutics, probes for cell staining and chaperones for promoting protein crystallization. We primarily cover publications on this topic from the past 10 years, with a focus on the different formats of multi-pass transmembrane proteins. Finally, the remaining challenges facing this field and new technologies developed to overcome a number of obstacles are discussed.
Reference90 articles.
1. Zhao, H., Dodds, M., Tasch, M., Gewe, M., Martinez, A., Hutton, M., Keeney, K., Pollock, A., Jester, B.W., and Khuong, N. (2022). Using synthetic activity to design ultra-potent antibody cocktails. bioRxiv.
2. The half-lives of IgG subclasses and specific antibodies in patients with primary immunodeficiency who are receiving intravenously administered immunoglobulin;Mankarious;J. Lab. Clin. Med.,1988
3. Single-Dose Nirsevimab for Prevention of RSV in Preterm Infants;Griffin;N. Engl. J. Med.,2020
4. Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease;Luytjes;Front. Immunol.,2019
5. Boosting therapeutic potency of antibodies by taming Fc domain functions;Kang;Exp. Mol. Med.,2019